Published in Neuroscience on May 01, 1994
Functional glycine receptor maturation in the absence of glycinergic input in dopaminergic neurones of the rat substantia nigra. J Physiol (2002) 0.98
Experimental manipulations blunt time-induced changes in brain monoamine levels and completely reverse stress, but not Pb+/-stress-related modifications to these trajectories. Behav Brain Res (2009) 0.83
High dendritic expression of Ih in the proximity of the axon origin controls the integrative properties of nigral dopamine neurons. J Physiol (2015) 0.78
Non-linear developmental trajectory of electrical phenotype in rat substantia nigra pars compacta dopaminergic neurons. Elife (2014) 0.78
Glutamatergic synaptic currents of nigral dopaminergic neurons follow a postnatal developmental sequence. Front Cell Neurosci (2015) 0.77
Coexistence of glutamatergic spine synapses and shaft synapses in substantia nigra dopamine neurons. Sci Rep (2015) 0.76
Abnormal Development of Glutamatergic Synapses Afferent to Dopaminergic Neurons of the Pink1(-/-) Mouse Model of Parkinson's Disease. Front Cell Neurosci (2016) 0.75
Functional upregulation of Ca(2+)-activated K(+) channels in the development of substantia nigra dopamine neurons. PLoS One (2012) 0.75
Postnatal development of the rat neostriatum: electrophysiological, light- and electron-microscopic studies. Dev Neurosci (1998) 1.17
Postnatal development of the electrical activity of rat nigrostriatal dopaminergic neurons. Brain Res Dev Brain Res (1990) 1.10
Analysis of dynamin isoforms in mammalian brain: dynamin-1 expression is spatially and temporally regulated during postnatal development. Proc Natl Acad Sci U S A (1992) 1.03
In vivo studies of the postnatal development of rat neostriatal neurons. Prog Brain Res (1993) 0.85
Postnatal development of synchronized network oscillations in the ferret dorsal lateral geniculate and perigeniculate nuclei. J Neurosci (1995) 0.84
Infection and low birth weight in a developing country. A study in an Indian village of Guatemala. Am J Dis Child (1975) 0.77
Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia. Psychopharmacology (Berl) (1987) 0.75